Side effects of testicular cancer predicted by machine learning

June 26, 2020

Testicular cancer is the most common cancer in young men. The number of new cases is increasing worldwide. There is a relatively high survival rate, with 95% surviving after 10 years - if detected in time and treated properly. However the standard chemotherapy includes cisplatin which has a wide range of long-term side effects, one of which can be nephrotoxicity.

"In testicular cancer patients, cisplatin-based chemotherapy is essential to ensure a high cure rate. Unfortunately, treatment can cause side effects, including renal impairment. However, we are not able to pinpoint who ends up having side effects and who does not," says Jakob Lauritsen from Rigshospitalet.

Patient data is key to knowledge

The researchers therefore asked the question: How far can we go in predicting nephrotoxicity risk in these patients using machine learning? First, it required some patient data.

"Using a cohort of testicular-cancer patients from Denmark- in collaboration with Rigshospitalet, we developed a machine learning predictive model to tackle this problem" says Sara Garcia, a researcher at DTU Health Technology, who, together with Jakob Lauritsen, are the first authors of an article published recently in JNCI Cancer Spectrum.

The high-quality of Danish patient records allowed the identification of key patients, and a technology partnership between DMAC and YouDoBio facilitated DNA collection from patients at their homes using postal delivered saliva kits. The project, originally funded by the Danish Cancer Society, saw the development of several analyses strategies of genomics and patient data, bringing forward the promise of artificial intelligence for integration of diverse data streams.

Best predictions for low-risk patients

A risk score for an individual to develop nephrotoxicity during chemotherapy was generated, and key genes likely at play were proposed. Patients were classified into high, low, and intermediate risk. For the high-risk, the model was able to correctly predict 67% of affected patients, while for the low-risk, the model correctly predicted 92% of the patients that did not develop nephrotoxicity.

"Understanding how and where AI technologies can be applied in clinical care, is increasingly important also in the future of responsible AI. Despite patient data complexity, the high quality of Danish registries and clinical research make it a great environment for exploring new data methodologies" says Ramneek Gupta.

"Being able to predict late side-effects will ultimately give us the opportunity for preventive action and improved quality of life" adds Gedske Daugaard who is joint senior author with Ramneek Gupta.
-end-


Technical University of Denmark

Related Chemotherapy Articles from Brightsurf:

Chemotherapy is used to treat less than 25% of people with localized sarcoma
UCLA researchers have found that chemotherapy is not commonly used when treating adults with localized sarcoma, a rare type of cancer of the soft tissues or bone.

Starved cancer cells became more sensitive to chemotherapy
By preventing sugar uptake, researchers succeeded in increasing the cancer cells' sensitivity to chemotherapeutic treatment.

Vitamin D could help mitigate chemotherapy side effects
New findings by University of South Australia researchers reveal that Vitamin D could potentially mitigate chemotherapy-induced gastrointestinal mucositis and provide relief to cancer patients.

Less chemotherapy may have more benefit in rectal cancer
GI Cancers Symposium: Colorado study of 48 patients with locally advanced rectal cancer receiving neoadjuvant chemotherapy, found that patients receiving lower-than-recommended doses in fact saw their tumors shrink more than patients receiving the full dose.

Male fertility after chemotherapy: New questions raised
Professor Delb├Ęs, who specializes in reproductive toxicology, conducted a pilot study in collaboration with oncologists and fertility specialists from the McGill University Health Centre (MUHC) on a cohort of 13 patients, all survivors of pediatric leukemia and lymphoma.

'Combo' nanoplatforms for chemotherapy
In a paper to be published in the forthcoming issue in NANO, researchers from Harbin Institute of Technology, China have systematically discussed the recent progresses, current challenges and future perspectives of smart graphene-based nanoplatforms for synergistic tumor therapy and bio-imaging.

Nanotechnology improves chemotherapy delivery
Michigan State University scientists have invented a new way to monitor chemotherapy concentrations, which is more effective in keeping patients' treatments within the crucial therapeutic window.

Novel anti-cancer nanomedicine for efficient chemotherapy
Researchers have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy.

Ending needless chemotherapy for breast cancer
A diagnostic test developed at The University of Queensland might soon determine if a breast cancer patient requires chemotherapy or would receive no benefit from this gruelling treatment.

A homing beacon for chemotherapy drugs
Killing tumor cells while sparing their normal counterparts is a central challenge of cancer chemotherapy.

Read More: Chemotherapy News and Chemotherapy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.